Enzo Biochem (ENZ) on Alert Status November 2012
November 20, 2012 in Economics
I’d like you to take a look at Enzo Biochem traded on the NYSE as ENZ.
Enzo Biochem, Inc., is a biotech company that operates in three discreet areas. Enzo Clinical Labs, Enzo Life Sciences, and Enzo Therapeutics.
Thay have had some interesting news lately. At the beginning of November 2012 they had a monumental verdict in their favor awarding them $48.6 million in direct infringement penalties.
The stock price jumped accordingly closing at $2.78 on November 2nd. ENZ closed at $2.00 October 31st.
Since then, ENZ put out 2 headlines in the middle of the month.
The first one is a press release announcing a presentation at a health care convention in New York. The second one is more promising to investors as it announces a new diagnostic test that assists in the early detection of lung cancer.
ENZO BIOCHEMS CLINICAL LABS INTRODUCES DIAGNOSTIC TEST Nov 13, 2012
ENZO BIOCHEM TO PRESENT AT LAZARD CAPITAL MARKETS 9TH ANNUAL HEALTHCARE CONFERENCE Nov 9, 2012
Keep your attention on ENZ as the volume has stayed consistant the whole month of November 2012.
Today’s closing price, as of Nov 19th, 2012 is $2.64 up +1.15% with 127,997 shares traded.
Visit ENZO Biochem
PLEASE NOTE WELL: This report/release/advertisement is a commercial advertisement and is for general information purposes only.
Full disclaimer here: http://bestotc.com/disclaimer/